Clinical Characteristics of Peripheral Neuropathy in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Single-Center Study in China

Neurological Involvement in Primary Systemic Vasculitis

(2019) Shanshan Zhang et al.   Frontiers in Neurology

Update on eosinophilic granulomatosis with polyangiitis

(2019) Shunsuke Furuta et al.   ALLERGOLOGY INTERNATIONAL

Overall Disability Sum Score for Clinical Assessment of Neurological Involvement in Eosinophilic Granulomatosis With Polyangiitis

(2018) Roberto Padoan et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review

(2018) Eveline Y. Wu et al.   Journal of Allergy and Clinical Immunology-In Practice

Clinical Characteristics and Treatment Response of Peripheral Neuropathy in the Presence of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Experience at a Single Tertiary Center

(2017) Hye-Jin Cho et al.   Journal of Clinical Neurology

Involvement of the Peripheral Nervous System in Polyarteritis Nodosa and Antineutrophil Cytoplasmic Antibodies–Associated Vasculitis

(2017) John B. Imboden   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Churg–Strauss syndrome

(2015) Antonio Greco et al.   AUTOIMMUNITY REVIEWS

Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management

(2015) Matthieu Groh et al.   European Journal of Internal Medicine

Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis

(2015) M.R. Hazebroek et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cardiac, renal, and central nervous system dysfunction with eosinophilia: eosinophilic granulomatosis with polyangiitis

(2015) Juliya Hemmett et al.   LANCET

Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence

(2015) Antonis Fanouriakis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

(2014) A J Mohammad et al.   ANNALS OF THE RHEUMATIC DISEASES

Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors

(2014) Maxime Samson et al.   AUTOIMMUNITY REVIEWS

Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg–Strauss syndrome)

(2014) Luc Mouthon et al.   JOURNAL OF AUTOIMMUNITY

A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients

(2012) Frank Moosig et al.   ANNALS OF THE RHEUMATIC DISEASES

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

(2012) J. C. Jennette et al.   ARTHRITIS AND RHEUMATISM

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

(2012) Cloé Comarmond et al.   ARTHRITIS AND RHEUMATISM

The Five-Factor Score Revisited

(2011) Loïc Guillevin et al.   MEDICINE

Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients

(2010) Camillo Ribi et al.   ARTHRITIS AND RHEUMATISM

Peripheral Nerve Society Guideline* on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary

(2010) Michael P. Collins et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Treatment of Churg-Strauss syndrome without poor-prognosis factors: A multicenter, prospective, randomized, open-label study of seventy-two patients

(2008) Camillo Ribi et al.   ARTHRITIS AND RHEUMATISM